Mylan to buy MS #Drug #Marketing rights from #Israel's Mapi Pharma

Mylan to buy MS #Drug #Marketing rights from #Israel's Mapi Pharma







(Reuters) – Mylan NV (MYL.O) will buy global marketing rights to an experimental multiple sclerosis … According to Israeli news website Haaretz.com here, Mylan is expected to invest a $20 million private placement in Mapi. Both companies did not …






Leave a Reply

Your email address will not be published. Required fields are marked *